Note: Semma Therapeutics's revenues are gauged from an analysis of company filings.
Semma Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
December 5, 2017
Complete list of funding rounds and total amounts in the Company Report
Semma Therapeutics's Income Statement (based on Industry Averages)
$ Millions (Industry Average)
Semma Therapeutics Revenue (Sales)
Cost of Goods Sold
Salaries and wages
Other Operating Expenses
Total Operating Expenses
EBIT (Earnings Before Interest and Taxes)
Trademark applications show the products and services that Semma Therapeutics is developing and marketing.
Semma Therapeutics doesn't have any recent trademark applications, indicating Semma Therapeutics is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
SEMMA THERAPEUTICS pharmaceutical drug development services; cell-based therapy development services, namely, medical research in the field of diabetes and metabolic disease; laboratory research services relating to pharmaceuticals; conducting research and clinical trials for others relating to medical devices, cell-based therapies and pharmaceuticals in the field of diabetes and metabolic disease
Determine whether Semma Therapeutics grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof Semma Therapeutics is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
Market Share of Competition: Semma Therapeutics vs. Largest Competitors
A competitive analysis shows these companies are in the same general field as Semma Therapeutics, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Semma Therapeutics.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Semma Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.